Medistim ASA
OSE:MEDI
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
M
|
Mehai Technology Ltd
BSE:540730
|
IN |
Medistim ASA
Inventory
Medistim ASA
Inventory Peer Comparison
Competitors Analysis
Latest Figures & CAGR of Competitors
| Company | Inventory | CAGR 3Y | CAGR 5Y | CAGR 10Y | ||
|---|---|---|---|---|---|---|
|
|
Medistim ASA
OSE:MEDI
|
Inventory
kr161.1m
|
CAGR 3-Years
12%
|
CAGR 5-Years
7%
|
CAGR 10-Years
13%
|
|
|
Lifecare AS
OSE:LIFE
|
Inventory
N/A
|
CAGR 3-Years
N/A
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
|
O
|
Observe Medical ASA
OSE:OBSRV
|
Inventory
kr7.5m
|
CAGR 3-Years
-3%
|
CAGR 5-Years
0%
|
CAGR 10-Years
N/A
|
|
Medistim ASA
Glance View
Medistim ASA engages in the development, manufacturing, and distribution of medical equipment and consumables. The company is headquartered in Oslo, Oslo. The company went IPO on 2004-05-28. The company develops, manufactures and distributes medical devices primarily for cardiac and vascular surgery. The firm provides intra-operative standard control applications designed to verify and document quality during surgery. Its product portfolio comprises systems, such as ultrasound imaging systems VeriQ C and MiraQ, as well as probes, which offer Transit Time Flow Measurement (TTFM). The Company’s activities are divided into four business areas: lease of equipment within cardiac surgery, capital and consumable sales within cardiac surgery, sales of electronic stethoscopes and distribution and sales of third party products. Furthermore, the Company is a parent of Medistim USA Inc, Medistim Deutschland GmbH, and Medistim Norge AS, among others.
See Also
What is Medistim ASA's Inventory?
Inventory
161.1m
NOK
Based on the financial report for Dec 31, 2025, Medistim ASA's Inventory amounts to 161.1m NOK.
What is Medistim ASA's Inventory growth rate?
Inventory CAGR 10Y
13%
Over the last year, the Inventory growth was 0%. The average annual Inventory growth rates for Medistim ASA have been 12% over the past three years , 7% over the past five years , and 13% over the past ten years .
